Nasal Cannula Market Size, Share & Trends Analysis Report By Type (Low Flow, High Flow), By Material, By End-use (Hospitals, Ambulatory Healthcare Services), By Region, And Segment Forecasts, 2024 - 2030

Nasal Cannula Market Size & Trends

“2030 Nasal Cannula market value to reach USD 11.47 billion”

The global nasal cannula market size was estimated to reach at USD 6.83 billion in 2023 and is projected to grow at a CAGR of 7.8% from 2024 to 2030. The significant factor driving this market growth is the increasing prevalence of respiratory diseases on a global scale. Data from the Institute for Health Metrics & Evaluation (IHME) indicates that between 1990 and 2019, there was a 28.5% increase in total deaths and prevalence of chronic respiratory diseases (CRDs).

The increase in healthcare spending by many countries, along with government efforts to provide affordable healthcare and raise awareness, is anticipated to drive the market further. Lifestyle changes, a growing number of smokers, environmental factors, and escalating air pollution are also significant contributors to the rising prevalence of respiratory illnesses, consequently boosting the market.

Furthermore, the global demand for nasal cannulas has been heightened by the global COVID-19 pandemic, with high-flow nasal cannula oxygen therapy being recommended as a standard treatment in the U.S. by the Center for Disease Control and Prevention (CDC). This led to a surge in demand for single-use nasal cannulas during the pandemic period.

The increasing demand for nasal cannulas is being met by a rising number of manufacturers and suppliers across the globe. These market leaders, with their extensive distribution networks, have made technologically advanced products readily available worldwide. The evolution of nasal cannulas, such as the use of silicone material, extra soft and latex-free designs, curved and flared cannulas, has greatly enhanced comfort and flexibility.

Moreover, the growing utilization of high flow nasal cannulas in the treatment of chronic respiratory diseases has expanded the application of nasal cannulas to patients of all age groups. Additionally, the surge in e-commerce platforms has facilitated the global availability of these products, even in home care settings, further driving the adoption of nasal cannulas and contributing to market growth.

Type Insights

“High flow segment is expected to witness growth at 8.7% CAGR”

The low flow segment emerged as the dominant force in the market and captured a revenue share of 62.7% in 2023. The increasing use of this type of nasal cannula in home care, ambulatory, and long-term care settings, particularly for stable patients requiring low or medium concentration, has contributed to this growth. Moreover, the affordability of low flow nasal cannula has further accelerated its adoption, resulting in a higher market share.

The high flow nasal cannula segment is anticipated to experience significant CAGR from 2024 to 2030 due to the increasing acceptance of high flow nasal cannulas as a means of respiratory support for critically ill patients. Furthermore, recent advancements have broadened the application of high flow nasal cannula in low-level healthcare facilities and even for home use.

Material Insights

“Silicone segment is expected to witness growth at 8.67% (CAGR)”

The plastic nasal cannula held the largest revenue share of 85.70% of the total revenue in 2023. This dominance can be attributed to its affordability and widespread availability, which ensures enhanced comfort and flexibility for patients, including those requiring long-term usage.

However, the silicone-made nasal cannula is gaining traction among individuals undergoing long-term oxygen therapy. This alternative is particularly favored by patients who have allergies to plastic materials or suffer from nasal and skin irritations, as well as inflammations.

End-use Insights

“Hospital segment is expected to witness growth at 8.1% (CAGR) from 2024 to 2030”

The hospital sector stood out as the key market segment with a revenue share of 46.0% in 2023. This is largely driven by the increasing utilization of high-flow nasal cannulas for severe respiratory distress requiring high flow oxygen. This trend highlights the hospital's prominent position in this segment. Furthermore, the expanding geriatric population and individuals with chronic respiratory conditions are poised to fuel growth in the long-term care center market segment for nasal cannulas.

The long-term care center segment is poised to witness noteworthy growth from 2024 to 2030, primarily attributed to the expanding geriatric population. Moreover, the demand for long-term care centers is expected to surge as a result of the growing number of patients experiencing long-term respiratory distress.

Regional Insights

“Mexico to witness market growth of CAGR 8.3%”

North America nasal cannula market emerged as the dominant player and captured the largest revenue share of 40.11% in 2023. This can be attributed to the increasing incidence of respiratory diseases like COPD and asthma, which account for approximately 80% of healthcare expenditure due to their chronic nature. Moreover, the presence of both local and international manufacturers in the region has facilitated the availability of nasal cannula products at affordable prices, thereby driving market growth.

U.S. Nasal Cannula Market Trends

The nasal cannula market in the U.S. dominated the market with a revenue share of 81.4% in 2023. The rise in respiratory conditions across the country played a pivotal role in propelling market growth. According to the Asthma and Allergy Foundation of America (AAFA) statistics from April 2022, around 25 million Americans were living with asthma in 2020, representing roughly 1 in 13 individuals.

Europe Nasal Cannula Market Trends

Europe nasal cannula market generated the second-highest revenue share of approximately 26.74% in 2023. This is attributed to ongoing R&D efforts and the substantial patient population in the region, leading to a notable demand for surgical procedures.

The nasal cannula market in the United Kingdom is growing steadily. The National Health Service (NHS) emphasizes evidence-based care and cost-effective interventions in delivering healthcare services to the public.

Asia Pacific Nasal Cannula Market Trends

The Asia Pacific nasal cannula market is witnessing remarkable growth and projected to witness a CAGR of 9.8% by 2030. This growth can be attributed to various factors such as a substantial population, escalating healthcare expenditure, and heightened awareness regarding respiratory ailments. Additionally, the region's advancing healthcare infrastructure, enhanced accessibility to medical services, and surging demand for home healthcare solutions are fueling the market's expansion.

The nasal cannula market in China shows promising growth opportunities due to the country's large population and high prevalence of chronic respiratory diseases caused by air pollution and other diseases.

Key Nasal Cannula Company Insights

The increasing incidence of respiratory illnesses, expanding elderly demographic, and growing acceptance are driving the expansion of the worldwide nasal cannula market. Moreover, the outbreak of COVID-19 in 2020 led to a sharp rise in the requirement for nasal cannulas in various countries, prompting major players in the industry to scale up production to efficiently cater to the demand.

The dedication to research and development and technological progress by major companies has led to the creation of a more versatile and user-friendly nasal cannula. This has allowed for the utilization of nasal cannula in treating a wide range of medical conditions. The widespread distribution network and the growth of e-commerce have facilitated the global availability of these products, resulting in a surge in adoption and market growth.

Prominent companies in the medical cannula market utilize acquisitions, mergers, expansions, collaborations, and product releases as key strategies to enhance revenue in various regions.

Recent Developments

• In January 2023, Inspira Technologies, a respiratory support technology company, revealed their convertible cannula device and its method of use, designed for the INSPIRA ART System. It has received a patent from the U.S. Patent and Trademark Office (USPTO), which encompasses 20 claims that were deemed unique, demonstrating inventive steps and industrial applicability.

Nasal Cannula Market Report Scope

Global Nasal Cannula Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global nasal cannula market report based on type, material, end-use, and region.

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Low Flow Nasal Cannula

  • High Flow Nasal Cannula

• Material Outlook (Revenue, USD Million, 2018 - 2030)

  • Plastic

  • Silicone

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Ambulatory Healthcare Services

  • Long Term Care Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Mexico

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • India

    • Australia

    • Japan

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait